Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D002152:Calorimetry, Differential Scanning / Q000379:methods; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D019073:HT29 Cells; D006801:Humans; D007700:Kinetics; D036103:Nanotechnology / Q000379:methods*; D017239:Paclitaxel / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D010316:Particle Size; D011108:Polymers / Q000737:chemistry* / Q000493:pharmacokinetics; D013499:Surface Properties; D014810:Vitamin E / Q000031:analogs & derivatives / Q000737:chemistry / Q000493:pharmacokinetics
D000972:Antineoplastic Agents, Phytogenic; D004337:Drug Carriers; D011108:Polymers; D014810:Vitamin E; D017239:Paclitaxel